Reports in category Model Portfolio
DIWALI PICKS (Large-Cap, Mid-Cap and Small-Cap stocks) by Nirmal Bank | |
Company: | Model Portfolio |
Brokerage: | Nirmal Bang |
Date of report: | October 12, 2022 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 43% |
Summary: | Selection of 5 large-cap stocks and 7 Mid and small-cap stocks across various diversified sectors such as Pharma, FMCG, Banking, Cement, Autos etc with up to 43% potential gain |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Diwali Dhamaka |
Six High-Conviction Stock Ideas By KR Choksey | |
Company: | Model Portfolio |
Brokerage: | KR Choksey |
Date of report: | October 3, 2022 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | High Conviction Stocks Idea Attributes • Company: a) Sound / resilient business; b) Consistent strong financials; c) High growth potential; and d) High return on invested capital • Industry: a) Market leaders / Strong brand value; b) High growth opportunities; c) Strong entry barriers • Management: a) Visionary Leadership; b) Strong & Effective Management; and c) High corporate access, including promoters and CXOs |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | KR Choksey |
Nifty Target (using FY24E EPS) is 19,425: ICICI Direct | |
Company: | Index, Model Portfolio |
Brokerage: | ICICI-Direct |
Date of report: | August 19, 2022 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | Present market offers an attractive risk-reward play to build a long term portfolio of quality companies, which have lean balance sheets, are capital efficient in nature and have growth longevity |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | ICICI-Direct |
Top 6 Festival Unlock Stocks By Axis Securities | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | September 25, 2021 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 19% |
Summary: | Festival Unlock Picks September 2021 |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Axis Securities |
Revised Nifty target is at 17,930 (22x P/E on FY23E EPS of Rs 815). Sensex target level is 59,800: ICICI Direct | |
Company: | Model Portfolio |
Brokerage: | ICICI-Direct |
Date of report: | September 9, 2021 |
Type of Report: | Sector Report |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | Positivity remains, stock specific action to prevail… |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | ICICI-Direct, NIFTY |
Best Specialty Chemicals Stocks To Buy Now: Motilal Oswal Research Report | |
Company: | Model Portfolio, Specialty Chemicals |
Brokerage: | Motilal Oswal |
Date of report: | June 1, 2021 |
Type of Report: | Sector Report |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | Specialty Chemicals: Genie is out! |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Motilal Oswal, Speciality Chemicals |
NIFTY target raised to 17400 + Top 16 Small Cap, Mid Cap and Large Cap Stocks To Buy | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | July 1, 2021 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 33% |
Summary: | Raise December NIFTY target to 17400 |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Axis Securities, NIFTY, Top Picks |
21 Stocks for Medium/Long Term SIP: HDFC Sec Research Report | |
Company: | Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | May 7, 2021 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | Staggered buying is recommended to benefit from any future falls and have better margin of safety |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | HDFC Sec |
Covid 2.0: Investment Ideas | |
Company: | Model Portfolio |
Brokerage: | Axis Securities |
Date of report: | April 23, 2021 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 39% |
Summary: | Reduce NIFTY50 target to 16100 but remain cautiously optimistic |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | Axis Securities |
Top 5 Pharma Stocks To Buy Now: Edelweiss Research Report | |
Company: | Model Portfolio, Sun Pharma |
Brokerage: | Edelweiss |
Date of report: | April 12, 2021 |
Type of Report: | |
Recommendation: | Buy |
Upside Potential: | 22% |
Summary: | SUN PHARMA entering into an earnings upgrade cycle |
Full Report: | Click here to view full post with link to download pdf file |
Tags: | 5 Best Pharma Stocks, Edelweiss |